Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-030473
Filing Date
2015-08-07
Accepted
2015-08-07 16:24:51
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2015 form10q.htm 10-Q 763550
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 21239
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12554
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12405
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7260
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 7212
  Complete submission text file 0001140361-15-030473.txt   5918573

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rnn-20150630.xml EX-101.INS 1601256
8 XBRL TAXONOMY EXTENSION SCHEMA rnn-20150630.xsd EX-101.SCH 57963
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20150630_cal.xml EX-101.CAL 51125
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20150630_def.xml EX-101.DEF 104335
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20150630_lab.xml EX-101.LAB 361882
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20150630_pre.xml EX-101.PRE 293930
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 151037819
SIC: 2834 Pharmaceutical Preparations